The Business Secretary recently announced the 15 winning projects and they show the creativity that it is possible to take in a regulatory environment to make it fit for the future, protecting the public and consumers while promoting economic growth and increasing productivity.
Before we continue, the research project that we’ve completed is opt-in, and we don’t look at anyone’s data without their express permission. We take privacy very seriously, but we also work with an amazing group of founders who are willing to pass on what they’ve learned to the next generation of founders going through the process. If you want to be included in our next round of research, you can find the survey links at the bottom of this blog post.
“Many major medical institutions, including UCSF, have long had the science and the technology to generate genomic test results,” said Kristen McCaleb, PhD, program manager for the GMI who partnered with the Helen Diller Comprehensive Cancer Center on the project. “The problem we’ve had is a lack of IT infrastructure to return those results to the clinicians who order the tests in a clearly actionable, doctor-friendly format.
The Scottish Funding Council said this week that a country-wide precision medicine initiative in Scotland has received up to £9.5 million ($12.3 million) in new funding. The funding includes £7.5 million from the council and up to £2 million from Scottish Enterprise, and will support the growth of precision medicine in Scotland managed by the Precision Medicine Scotland Innovation Centre (formerly the Stratified Medicine Scotland Innovation Centre). The newly launched phase 2 of the center will continue to act as a catalyst for partnerships between industry, academia, and clinical entities. In phase 1 the Innovation Centre produced several large-scale projects in areas including ovarian cancer, rheumatoid arthritis, esophageal cancer, and multiple sclerosis. The center said it expects to be able to attract around £4.2 million in income from other sources.